Literature DB >> 21382046

Placenta perfusion has hematopoietic and mesenchymal progenitor stem cell potential.

Nikos Tsagias1, Iro Koliakos, Maria Lappa, Vasileios Karagiannis, George G Koliakos.   

Abstract

BACKGROUND: Placenta is a valuable source of stem cells for cell therapy and future application in the field of regenerative medicine. This is due to the plasticity and the immunomodulatory effects of the stem cells that it contains. In this study we present a totally closed method for hematopoietic and nonhematopoietic stem cell isolation from human term placenta. STUDY DESIGN AND METHODS: Sixty-eight placenta units were collected and manipulated for the residual fetal blood drainage. After delivery, placenta flushing with citrate-phosphate-dextrose-adenine was evaluated.
RESULTS: Placenta flushing using a totally closed system led to a significant amount of hematopoietic progenitor cells and multipotent mesenchymal stem cells (MSCs) without additional microbial risk, free of maternal cell contamination.
CONCLUSION: Traditionally discarded after childbirth, the term placenta now appears to be an easily accessible and abundant source of diverse origin stem cells suitable for banking strategies and for future clinical applications, including adult therapy.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2011        PMID: 21382046     DOI: 10.1111/j.1537-2995.2011.03077.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  1 in total

1.  Potential role of intravitreal human placental stem cell implants in inhibiting progression of diabetic retinopathy in type 2 diabetes: neuroprotective growth factors in the vitreous.

Authors:  Sergio Zaccaria Scalinci; Lucia Scorolli; Giulia Corradetti; Daniela Domanico; Enzo Maria Vingolo; Alessandro Meduri; Mario Bifani; Duilio Siravo
Journal:  Clin Ophthalmol       Date:  2011-05-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.